Hexarelin

Overview

Hexarelin (examorelin) is a synthetic hexapeptide growth-hormone-releasing peptide that activates the ghrelin receptor (GHS-R1a) to trigger growth hormone release, and is often described as one of the more potent GHRPs for an acute GH spike. It is not FDA-approved for any indication and has only been studied in small, mostly short-term human pharmacology and cardiovascular research settings. A notable limitation is that the GH response tends to wane with repeated use as the receptor desensitizes, and it can raise cortisol and prolactin. Claims around muscle growth, fat loss, and heart-protective effects remain preliminary and unproven for routine use.

Commonly Reported Uses

These are uses commonly discussed or marketed by users and vendors — not a list of proven or approved benefits, and not a recommendation.

• Growth hormone stimulation / GH-axis research (research use; not an approved treatment)
• Muscle growth and recovery (marketed claim; human efficacy evidence limited)
• Cardiovascular/cardioprotective effects (early research only; not an approved use)
• Fat loss (marketed claim; human evidence limited)

What to Track

Data points you and your clinician might monitor. For observation only — not a diagnostic protocol.

• Labs — IGF-1 and a clinician-monitored GH response, plus prolactin/cortisol if a clinician is watching off-target effects
• InBody/DEXA — skeletal muscle mass and body-fat % against a baseline
• WHOOP — recovery score and sleep stages
• Subjective daily check-ins — energy, appetite, and any flushing or fatigue

Sources & References

1. [1]Examorelin (Hexarelin) — PubChem
2. [2]List of drugs banned by the World Anti-Doping Agency — Wikipedia